Toolkit for managing diabetes after hospital discharge
Implementation and Testing of a Diabetes Discharge Intervention to Improve Safety During Transitions of Care
This study is testing a new toolkit to help people who need insulin manage their diabetes better after leaving the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Northwestern University Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT05663931 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to implement the Diabetes Mellitus (DM) Discharge Toolkit during hospital discharge to evaluate its effectiveness for patients newly requiring insulin. Participants will be randomly assigned to either receive standard discharge training or the enhanced training that includes the DM Discharge Toolkit. The study will involve up to 120 participants and will assess how the toolkit impacts their ability to manage diabetes at home. The goal is to improve transitions of care for patients with insulin-dependent diabetes.
Who should consider this trial
Good fit: Ideal candidates are English-speaking adults aged 18 and older who are newly prescribed insulin at the time of hospital discharge.
Not a fit: Patients who are non-English speaking, unable to give informed consent, or not diagnosed with diabetes will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the self-management of diabetes for patients transitioning from hospital to home.
How similar studies have performed: Other studies have shown promising results with similar interventions aimed at improving diabetes management during transitions of care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * English speaking patients * 18 years of age and older * Expected survival \>90 days * Need for new insulin at time of hospital discharge Exclusion Criteria: * Patients with the inability to give informed consent * Non-English speaking * Not diagnosed with diabetes * Not been newly prescribed insulin
Where this trial is running
Chicago, Illinois
- Northwestern Memorial Hospital — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Amisha Wallia, MD — Northwestern University
- Study coordinator: Christina Coventry, MSN, RN
- Email: christina.coventry@northwestern.edu
- Phone: 312-908-5565
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.